TIMA FOUNDATION has a total of 29 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are NATURALENDO TECH CO LTD, ESSENTYS AB and POMYTKIN IGOR ANATOLIEVICH.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Republic of Korea | 4 | |
#4 | United States | 3 | |
#5 | EAPO (Eurasian Patent Organization) | 2 | |
#6 | Hong Kong | 2 | |
#7 | Japan | 2 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | Taiwan | 1 | |
#11 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Foods | |
#4 | Special foods | |
#5 | Peptides | |
#6 | Veterinary instruments or methods | |
#7 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Inufusa Haruhiko | 16 |
#2 | Matuschka-Greiffenclau Markus Graf Von | 8 |
#3 | Graf Matuschka Von Greiffencla | 5 |
#4 | Matuschka Greiffenclau Markus | 2 |
#5 | Graf Matuschka Von Greiffencla Markus | 1 |
#6 | Graf Matuschka Von Greiffenclau Markus | 1 |
#7 | Inufusa Haruhik | 1 |
#8 | Matuschka-Greiffenclau Markus | 1 |
#9 | Matuschka Von Greiffenclau Markus Graf | 1 |
#10 | Matuschka Greiffenclau Markus Graf Von | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015165947A1 | Composition against sleep apnea | |
CN104053368A | Composition For Protection Against Cell-damaging Effects | |
WO2012095509A1 | Composition for accelerating alcohol metabolism and for reducing the risk of alcohol induced diseases | |
TW201309282A | Composition for accelerating alcohol metabolism and for reducing the risk of alcohol induced diseases | |
EP2594141A1 | Composition for protection against cell-damaging effects | |
KR20090100385A | Novel compositions and uses thereof | |
US2009145366A1 | Optimized oral glucose tolerance test | |
EP2057905A1 | Composition for moderating Triglyceride and Cholesterol Levels | |
EP1932542A1 | Antioxidant composition and its use in diabetes | |
WO2007017139A1 | Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases | |
EP1832604A1 | Use of IEX-1 for the treatment of glioma tumors |